Biotech Bolsters ADC Pipeline Through Atreca Asset Buy
Source: Dr. David Nierengarten  (12/26/23)
Biotech Immunome Inc. recently announced a purchase agreement with Altreca, noted Wedbush. More >

Co. To Build, Demo Fuel Cell Vehicles Run on Clean Hydrogen
Source: Streetwise Reports  (12/22/23)
This is part of its plan for North America, to eventually include the assembly of these zero-emission vehicles plus the production of green hydrogen in Quebec. Learn why experts believe now is the time to invest in this cleantech company. More >

US Biotech's Anti-Fungal Wins European Approvals
Source: Ed Arce  (12/22/23)
Recently, Cidara Therapeutics Inc. secured European Commission (EC) approval for its lead anti-fungal candidate Rezafungin to treat invasive candidiasis infections in adults, noted H.C. Wainwright & Co. More >

Canadian Silver Co. Will See Big Changes in 2024
Source: Michael Ballanger  (12/22/23)
Michael Ballanger of GGM Advisory Inc. takes a look at the current state of the market and shares one stock he believes will see some big positive changes in the new year. More >

With Missiles in Red Sea, More Efficient Anti-Drone Methods Needed
  (12/22/23)
McAlinden Research shares a deep dive into the current costs to counter militant armaments and how drone warfare is evolving. More >

Siren Gold a Christmas Gift Stock
Source: Barry Dawes  (12/21/23)
Barry Dawes of Martin Place Securities shares his view on why one gold stock may be an early Christmas present for investors. More >

Biotech Co. Reports Encouraging ALS Data but FDA Wants More
Source: Dr. Jonathan Aschoff  (12/21/23)
Salt Lake City-based Clene Inc. reported both encouraging clinical data and a regulatory setback for its ALS drug candidate CNM-Au8, reported Roth MKM. More >

Green Tech Co. Gathers Capital for Ecuador Bioleaching Plant
Source: Streetwise Reports  (12/20/23)
This environmental company gives an update on private placement funding as it works toward closing on millions in green bonds to build its long-anticipated bioleaching plant in Ecuador. More >

Massive Undeveloped Copper Resource Successfully Renews Major License
Source: Streetwise Reports  (12/20/23)
When we last looked at Freeport Resources Inc. and how it's positioning itself to meet the coming copper crunch, the company has just secured some CA$2 million in new financing. Now, it has put some of that capital to work, securing a major license renewal. More >

Drill Results Confirm Promising Targets in Golden Triangle
Source: Streetwise Reports  (12/20/23)
Seabridge Gold Inc. announces results from drilling and survey work on its 100%-owned Iskut property in northwest British Columbia's Golden Triangle. More >

Osisko Pursues Clearer Path: Better Late Than Never
Source: Adrian Day  (12/20/23)
Several resource companies reported good news this past week, much of it long anticipated but welcome all the same. After the run-up in stock prices this month with the increase in the gold price and following the news, Global Analyst Adrian Day shares his recommendations. More >

Pharma Co. May Have Accelerated FDA Approval in 2024
Source: Edward White  (12/20/23)
TRACON Pharmaceuticals Inc. provided an update on enrollment progress for their ongoing Phase 2 ENVASARC clinical trial testing the drug envafolimab to treat sarcoma, reported H.C. Wainwright & Co. More >

'Just Silver' Royalty Co. Looks To Shake Up Sector
Source: Streetwise Reports  (12/19/23)
Silver Crown Royalty Company says it's simplifying the process for investors to gain exposure to royalties and streaming. Read to see what other public companies are aligned with Silver Crown's business and what makes this soon-to-be public company different. More >

Canadian Co. Represents an Ideal Leverage Play on the Price of Gold
Source: Michael Ballanger  (12/19/23)
Michael Ballanger of GGM Advisory Inc. shares why he believes Getchell Gold is a stock worth watching. More >

Lithium Co. Will Be a Substantial Outperformer
Source: Michael Ballanger  (12/19/23)
Michael Ballanger of GGM Advisory Inc. shares a quick note about why he has faith in Volt Lithium Corp. More >

Bioscience Co. Expands Collaboration
Source: Dr. Jonathan Aschoff  (12/19/23)
This bioscience company's price target implies 680% upside, according to a Roth MKM report. More >

Energy Co. Increases Holdings in JV in South Africa
Source: Stephane Foucaud  (12/18/23)
Recently, Chariot Ltd. announced it had acquired increased holdings in South African joint venture, noted Auctus Advisors. More >

Promising Biotech Selling Way Under Cash Value
Source: Ron Struthers  (12/18/23)
Nkarta is using CRISPR technology for cell therapies for leukemia. The FDA just approved a similar cell therapy treatment for Vertex using the same CRISPR technology. Nkarta is trading well below cash value and has a significant short position sinking underwater. More >

Economic Five-Alarm
Source: Michael Ballanger  (12/18/23)
Michael Ballanger of GGM Advisory Inc. shares his thoughts on the current state of the stock markets as well as a few stocks he believes are worth looking into. More >

Fiji-Based Gold Project Reveals Bonanza-Grade Find
Source: Streetwise Reports  (12/15/23)
Lion One has released assay results from its Tuvatu alkaline gold project in Fiji, revealing discoveries of 1,986.23 g/t of gold. Read on to see why analysts like this company's stock. More >

Near Term is Catalyst Rich for B.C. Uranium Explorer
Source: Siddharth Rajeev  (12/15/23)
Through upcoming drill programs, this company and its partners are "growing mergers and acquisitions prospects in the junior uranium space," noted a Fundamental Research Corp. report. More >

Gold Co. Identifies Porphyry Target at Project in B.C.
Source: Mike Kozak  (12/15/23)
Early drill data show the presence of gold mineralization at this explorer's second asset, noted a Cantor Fitzgerald research report. More >

Gold Exploration Company Reveals Exciting Assay Results
Source: Streetwise Reports  (12/15/23)
Collective Mining Ltd. has released the assay results from the Apollo system. Read on to see why one newsletter writer likes this stock. More >

Drilling Confirms Porphyry Potential at BC Project
Source: Taylor Combaluzier  (12/15/23)
Recently, Seabridge Gold announced positive results from its Snip North target at the Iskut project in British Columbia's Golden Triangle, noted a Red Cloud research note. More >

Texas Biotech Advances Lead Candidate in Resistant AML
Source: Dr. Jonathan Aschoff  (12/14/23)
Recently, Texas-based biotech Bio-Path Holdings Inc. announced it had completed the first safety cohort of a Phase 1/1b trial evaluating the developmental drug BP1002 in acute myeloid leukemia (AML). Read on to see what one Roth analyst has to say about the company's stock. More >